Pidilizumab Biosimilar (PDCD1 / PD-1 / CD279 Reference Antibody)
Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research.
Product Specifications
Target
Pidilizumab Biosimilar (Anti-PDCD1 / PD-1 / CD279 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology; Immunology & Inflammation; Cell Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6348508 1.0 µg DNA
Adamtsl3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details